JAMP PHARMA

Serial Number 79390054
Registration 7583174
700

Registration Progress

Application Filed
Sep 27, 2023
Under Examination
Approved for Publication
Oct 1, 2024
Published for Opposition
Oct 1, 2024
Registered
Dec 3, 2024

Trademark Image

JAMP PHARMA

Basic Information

Serial Number
79390054
Registration Number
7583174
Filing Date
September 27, 2023
Registration Date
December 3, 2024
Published for Opposition
October 1, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 3, 2024
Registration
Registered
Classes
005 035

Rights Holder

JAMP PHARMA CORPORATION

03
Address
1310 rue Nobel
Boucherville QC J4B 5H3
CA

Ownership History

JAMP PHARMA CORPORATION

Original Applicant
03
CA

JAMP PHARMA CORPORATION

Owner at Publication
03
CA

JAMP PHARMA CORPORATION

Original Registrant
03
CA

Legal Representation

Attorney
Brent E.. Routman

USPTO Deadlines

Next Deadline
1798 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20241203)
Due Date
December 03, 2030
Grace Period Ends
June 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Dec 3, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 3, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 1, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 23, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 23, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 15, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 24, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 24, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 14, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 3, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 23, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 22, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, prescription and non-prescription pharmaceutical preparations and drugs for the treatment of respiratory system diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, namely, brain diseases, spinal cord diseases and injuries, movement and seizure disorders, genitourinary diseases and disorders, namely, pelvic diseases, urological diseases and sexually transmitted diseases, gynecological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal system diseases and disorders, namely, connective tissue diseases, bone diseases, back pain, fractures, sprains, cartilage injuries, endocrine and metabolic diseases and disorders, namely, hyperlipidemia, hypercalcemia, diabetes, gout, anemia, cholestatic liver diseases, namely, primary biliary cirrhosis (PBC), skin diseases and disorders, namely, dermatitis and fungal diseases, ocular diseases and disorders, allergies, cold, cough, sinus diseases and disorders, hypertension, sexual diseases and disorders, prostate diseases and disorders, cancer, obesity, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, infectious diseases and disorders, namely, respiratory infections, eye infections, topical infections, immunological diseases, namely, autoimmune diseases, immunologic deficiency syndrome, viral diseases and disorders, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids), parasitic diseases, namely, malaria, parasitic infections, namely, intestinal worms, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, dental and oral diseases, namely, mouth diseases, esophageal diseases and toothaches, motion sickness, carpal tunnel syndrome and pain, namely, headaches, migraines, back pain, pain from burns, neuropathic pain, chronic pain associated with osteoarthritis of the knee, transplant rejection, hyperfibrinolysis, hereditary angioedema, drug abuse and biosimilar biologic drugs for the treatment of inflammatory diseases and disorders, namely, inflammatory connective tissue diseases and inflammatory bowel diseases, skin diseases and disorders, namely, psoriasis and hidradenitis suppurativa, ocular diseases and disorders, namely, inflammation of the uvea or uveal tract; natural health product preparations, namely, dietary supplements, nutritional supplements and herbal supplements for general health and well-being, namely, food supplements containing natural plant extracts, natural algae, natural algae extracts and fungus extracts, vitamins, mineral supplements, amino acids, fatty acids, dietary fibre, probiotics dietary supplements, enzyme and protein supplements in powder, capsule, tablet and liquid form, all for maintaining brain health, for neuroprotection, for improving or preserving cognition, memory and brain function; vitamins and nutritional supplements, namely, vitamins and nutritional supplements in the form of calcium, electrolyte drinks, energy bars, energy drinks, juice drinks, lecithin, minerals, vitamins for pharmaceutical, medicinal and therapeutic use
Class 035
Business management with relation to strategy, marketing, production, personnel and retail sale matters of pharmaceutical preparations, drugs and biosimilar biologic drugs for promoting optimal health of the human body, namely, prescription and non-prescription pharmaceutical preparations, vitamins and nutritional supplements

Additional Information

Design Mark
The mark consists of a circular design interrupted by a curved opening near the bottom-center of the design, to the left of the stylized wording "JAMP PHARMA".

Classification

International Classes
005 035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"